Ilaria Bertolini

Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients

Marzia Del Re, Ilaria Bertolini, Stefania Crucitta et al. · Breast Cancer Research and Treatment · 2019 · 100 citations

Medicine, Cell Biology, Oncology +17

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

Patrizia Vici, Laura Pizzuti, Andrea Michelotti et al. · Oncotarget · 2017 · 70 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study

Patrizia Vici, Laura Pizzuti, Clara Natoli et al. · Breast Cancer Research and Treatment · 2014 · 49 citations · Full text

Medicine, Oncology, Breast Oncology +16

Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer

Samuel Martel, Elena Poletto, Arlindo R. Ferreira et al. · The Breast · 2017 · 44 citations · Full text

Medicine, Cancer Biology, Oncology +16

“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome

Patrizia Vici, Laura Pizzuti, Isabella Sperduti et al. · Oncotarget · 2016 · 43 citations · Full text

Medicine, Oncology, Breast Oncology +7